Analgesic effects of ultrasound-guided maxillary nerve block for tonsillectomy: a prospective randomized, double-blind, placebo-controlled trial
Not Applicable
Recruiting
- Conditions
- tonsillectomy
- Registration Number
- JPRN-UMIN000044166
- Lead Sponsor
- Sapporo Medical University School of Medicine, Department of Anesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are allergic to the study drug, blood coagulation disorders, chronic opioid use, supected peripheral neuropathy (e.g., severe diabetes mellitus), pregnancy, mental disorders, patients who were not extubated in the operating room after surgery for some reason, and other patients who, at the discretion of the physician in charge, are considered inappropriate for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rest visual analog scale (VAS) at returning the ward, 2hr, 4hr, 8hr, 24hr after the returning
- Secondary Outcome Measures
Name Time Method swallowing visual analog scale (VAS) at returning the ward, 2hr, 4hr, 8hr, 24hr after the returning Fentanyl consumption and rescue frequency from extubation to 24 hours postoperatively Quality of recovery score (QoR-40) at 24 hours postoperatively Intraoperative remifentanil use Time from discharge to first rescue administration Time to start postoperative drinking water Time to start postoperative drinking and food intake Incidence of adverse events (local anesthetic poisoning, hematoma formation, local infection, postoperative nausea and vomiting due to nerve block, and hypoxia) Hypoxic events (SpO2<92%, airway-related adverse events requiring tracheal intubation and ventilatory management)